| Walgreens #1829 | |
| Carr 308, Km 0.7 Bo Pedrenales, Cabo Rojo, Puerto Rico 00623 | |
| (787) 851-3363 |
| Name | Walgreens #1829 |
|---|---|
| Organization Name | Walgreen Co |
| Location | Carr 308, Km 0.7 Bo Pedrenales, Cabo Rojo, Puerto Rico 00623 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (787) 851-3363 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Opioid-related deaths continue to take the lives of thousands in the U.S. each year, with non-fatal opioid overdoses as a significant risk factor for a subsequent fatal overdose.
An innovative model of dementia care that significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains, has now been used to treat over 1,000 patients. The Aging Brain Care model was developed by researcher-clinicians from the Regenstrief Institute and the Indiana University School of Medicine.
Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
› Verified 7 days ago
| NPI Number | 1174839450 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS # 01829 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | Carr #308 Km. 0.7, Bo Pedrenales, Cabo Rojo, PR 00623 |
| Phone Number | 787-851-3363 |
News Archive
Opioid-related deaths continue to take the lives of thousands in the U.S. each year, with non-fatal opioid overdoses as a significant risk factor for a subsequent fatal overdose.
An innovative model of dementia care that significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains, has now been used to treat over 1,000 patients. The Aging Brain Care model was developed by researcher-clinicians from the Regenstrief Institute and the Indiana University School of Medicine.
Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
› Verified 7 days ago
News Archive
Opioid-related deaths continue to take the lives of thousands in the U.S. each year, with non-fatal opioid overdoses as a significant risk factor for a subsequent fatal overdose.
An innovative model of dementia care that significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains, has now been used to treat over 1,000 patients. The Aging Brain Care model was developed by researcher-clinicians from the Regenstrief Institute and the Indiana University School of Medicine.
Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
› Verified 7 days ago
B & S Medical Rentals Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: Carr 308 Ave Santos Ortiz, Cabo Rojo, Puerto Rico 00623 Phone: (787) 254-0276 | |
Walgreens #1829 Type: Durable Medical Equipment & Medical Supplies Supplier Location: Carr 308, Km 0.7 Bo Pedrenales, Cabo Rojo, Puerto Rico 00623 Phone: (787) 851-3363 |